Advertisement
Screener

BioNTech SE (BNTX) Patents: Active

BioNTech SE Active Patents

42 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-05-10: Application 18660672; Invention ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF; Applicant BioNTech SE; Status Patented Case.
  • 2023-11-21: Application 18515879; Invention METHOD FOR REDUCING IMMUNOGENICITY OF RNA; Applicant BioNTech SE; Status Patented Case.
  • 2023-06-26: Application 18341590; Invention CORONAVIRUS VACCINE; Applicant BioNTech SE; Status Patented Case.
  • 2023-04-20: Application 18303642; Invention Compositions and Methods for Diagnosis and Treatment of Cancer; Applicant BioNTech SE; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-05-1018660672ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOFBioNTech SE
Genmab A/S
Patented Case2025-09-0912410258US20240376221A1
Kristel Kemper
Maarten van der Kroef
Dennis Verzijl
Andrea Gorlani
Pauline Linda de Goeje
Lars Guelen
David Satijn
Esther C. W. Breij
Ugur Sahin
Sina Fellermeier-Kopf
Maren Köhne
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
Germany
GUSTILO, ESTELLA M
2023-11-2118515879METHOD FOR REDUCING IMMUNOGENICITY OF RNABioNTech SEPatented Case2025-11-0412460198US20240084288A1
Katalin Kariko
Ugur Sahin
United States
Germany
BERTOGLIO, VALARIE E
2023-06-2618341590CORONAVIRUS VACCINEBioNTech SEPatented Case2024-01-2311878055US20240000921A1
Alexander Muik
Kena Anne Swanson
Qi Yang
Hui Cai
Ugur Sahin
Kayvon Modjarrad
Germany
United States
United States
United States
Germany
United States
CHESTNUT, BARRY A
2023-04-2018303642Compositions and Methods for Diagnosis and Treatment of CancerBioNTech SEPatented Case2026-01-0612516104US20240002471A1
Ugur Sahin
Bonny Gaby Lui
Nadja Salomon
Joycelyn Wüstehube-Lausch
Matin Daneschdar
Hans-Ulrich Schmoldt
Markus Fiedler
Germany
Germany
Germany
Germany
Germany
Germany
Germany
MIKNIS, ZACHARY J
2023-03-2018186914CORONAVIRUS VACCINEBioNTech SEPatented Case2025-01-2812208136US20240042011A1
Alexander Muik
Kena Anne Swanson
Qi Yang
Hui Cai
Ugur Sahin
Kayvon Modjarrad
Germany
United States
United States
United States
Germany
United States
SIFFORD, JEFFREY MARK
2023-03-1518184120BINDING AGENTS BINDING TO EPCAM AND CD137BioNTech SE
Genmab A/S
Patented Case2025-08-2612398214US20230295335A1
Andreea IOAN
Esther Cornelia Wilhelmina BREIJ
Lars GUELEN
David P.E. SATIJN
Ugur SAHIN
Alexander MUIK
Kristina NÜRMBERGER
Sina FELLERMEIER-KOPF
Bart-Jan DE KREUK
Richard HIBBERT
Janine SCHUURMAN
Aran Frank LABRIJN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
Germany
Germany
Netherlands
Netherlands
Netherlands
Netherlands
NATARAJAN, MEERA
2022-11-2918071499CORONAVIRUS VACCINEBioNTech SEPatented Case2025-01-0712186387US20230338512A1
Alexander Muik
Asaf Poran
Kena Anne Swanson
Qi Yang
Hui Cai
Ugur Sahin
Germany
United States
United States
United States
United States
Germany
SIFFORD, JEFFREY MARK
2022-11-1617988742CORONAVIRUS VACCINEBioNTech SEPatented Case2024-11-0512133899US20240075165A1
Ugur Sahin
Alptekin Güler
Andreas Kuhn
Alexander Muik
Annette Vogel
Kerstin Walzer
Sonja Witzel
Stephanie Hein
Özlem Türeci
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
FOLEY, SHANON A
2022-10-2518049593MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AND TRANSLATION EFFICIENCYBioNTech SEPatented Case2025-08-1212385049US20230193296A1
Ugur Sahin
Silke Holtkamp
Ozlem Tureci
Sebastian Kreiter
Germany
Germany
Germany
Germany
HIBBERT, CATHERINE S
2022-08-2317893742IN VITRO TRANSCRIPTION TECHNOLOGIESBioNTech SEPatented Case2025-05-2012305210US20230183769A1
Irena Rabe
Maximilian Buff
Thomas Ziegenhals
Johanna Drögemüller
Andreas Kuhn
Stephanie Fesser
Rodney Gene Combs
Nicole Star Eschmann
Jennifer Ann Schoborg Romine
Jenna Kathryn Williamson
Germany
Germany
Germany
Germany
Germany
Germany
United States
United States
United States
United States
GIBBS, TERRA C
2022-05-1817777977Prame TCR Receptors And Uses ThereofBioNTech SEPatented Case2026-05-1912630607US20220401484A1
Manon Weis
Patrik Kehler
Maria Gerget
Christian Krendl
Susanne Wilde
Germany
Germany
Germany
Germany
Germany
GURLEY, JAMI MICHELLE
2022-03-1817698829CORONAVIRUS VACCINEBioNTech SEPatented Case2024-03-1211925694US20230075979A1
Ugur Sahin
Alptekin Güler
Andreas Kuhn
Alexander Muik
Annette Vogel
Kerstin Walzer
Sonja Witzel
Stephanie Hein
Özlem Türeci
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
SHIN, DANA H
2022-02-1017669117SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7BIONTECH SEPatented Case2024-05-2111987569US20220242845A1
Christophe HENRY
Germany
OTTON, ALICIA L
2022-02-0117590550SUBSTITUTED IMIDAZOQUINOLINESBIONTECH SEPatented Case2024-08-0612054485US20220227756A1
Christophe HENRY
Germany
CHANDRAKUMAR, NIZAL S
2021-12-3017565921RNA CONSTRUCTS AND USES THEREOFBioNTech SEPatented Case2024-04-0911951185US20220273820A1
Ugur Sahin
Gábor Boros
Azita Josefine Mahiny
Jonas Reinholz
Katalin Karikó
Germany
Germany
Germany
Germany
United States
EPPS-SMITH, JANET L
2021-12-3017565842RNA CONSTRUCTS AND USES THEREOFBioNTech SEPatented Case2023-10-1011779659US20220249704A1
Ugur Sahin
Gábor Boros
Azita Josefine Mahiny
Jonas Reinholz
Katalin Karikó
Germany
Germany
Germany
Germany
United States
BURKHART, MICHAEL D
2021-12-2117621396IL2 AgonistsBioNTech SEPatented Case2026-06-0212643930US20220356223A1
Ugur Sahin
Sina Fellermeier-Kopf
Alexander Muik
Mathias Vormehr
Lena Mareen Kranz
Germany
Germany
Germany
Germany
Germany
MCCOLLUM, ANDREA K
2021-12-2017621136RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH SEPatented Case2026-06-3012667621US20220362388A1
Heinrich HAAS
Jorge MORENO HERRERO
Anne Marion Genevieve SCHLEGEL
Stephanie ERBAR
Germany
Germany
Germany
Germany
VIJAYARAGHAVAN, JAGAMYA NMN
2021-10-0617495104STABLE FORMULATIONS OF LIPIDS AND LIPOSOMESBioNTech SEPatented Case2025-02-1112220484US20220023212A1
Heinrich Haas
Isaac Hernan Esparza Borquez
Germany
Germany
TIEN, LUCY MINYU
2021-09-1717593391PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH SEPatented Case2025-10-0712433911US20220143069A1
Heinrich HAAS
Sebastian HÖRNER
Thomas Michael HILLER
Germany
Germany
Germany
AMICK, THOMAS RUSSE
2021-06-2817360438MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137BioNTech SE
GENMAB A/S
Patented Case2024-09-0312077596US20220033510A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Friederike GIESEKE
Ugur SAHIN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
JOHANSEN, PETER N.
2021-06-2817360437MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137BioNTech SE
GENMAB A/S
Patented Case2024-03-2611939388US20220064317A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Friederike GIESEKE
Ugur SAHIN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
JOHANSEN, PETER N.
2021-06-1117345628MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137BioNTech SE
GENMAB A/S
Patented Case2022-09-1311440966US20210317225A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Friederike GIESEKE
Ugur SAHIN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
GAMBEL, PHILLIP
2021-04-1617233396CORONAVIRUS VACCINEBioNTech SEPatented Case2023-01-1011547673
Ugur Sahin
Alptekin Güler
Andreas Kuhn
Alexander Muik
Annette Vogel
Kerstin Walzer
Sonja Witzel
Stephanie Hein
Özlem Türeci
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
FOLEY, SHANON A
2021-03-3117281697RNA Particles Comprising PolysarcosineBIONTECH SE
Johannes Gutenberg-Universität Mainz
Patented Case2025-09-2312419965US20220001025A1
Matthias Barz
Benjamin Weber
Heinrich Haas
Philipp Heller
Sara Nogueira
Anne Schlegel
Germany
Germany
Germany
Germany
Germany
Germany
SHOMER, ISAAC
2021-03-2317209926CYTOTOXIC IMMUNOSTIMULATING PARTICLES AND USES THEREOFBIONTECH SEPatented Case2025-04-0112263215US20210205447A1
Steve PASCOLO
Switzerland
JOHNSON, ALLISON MARIE
2021-02-1017172698BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOFBIONTECH SE
GENMAB A/S
Patented Case2026-03-1012570751US20210269541A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Ugur SAHIN
Friederike GIESEKE
Alexander MUIK
Christian GRUNWITZ
Edward VAN DEN BRINK
Dennis VERZIJL
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
Germany
Germany
Netherlands
Netherlands
DUFFY, BRADLEY
2021-02-1017172694BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOFBIONTECH SE
GENMAB A/S
Patented Case2022-10-0411459395US20210163616A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Ugur SAHIN
Friederike GIESEKE
Alexander MUIK
Christian GRUNWITZ
Edward VAN DEN BRINK
Dennis VERZIJL
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
Germany
Germany
Netherlands
Netherlands
DUFFY, BRADLEY
2021-02-0817170826PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPYBioNTech SEPatented Case2024-08-1312059498US20210161818A1
Heinrich Haas
Sebastian Hörner
Isaac Hernan Esparza Borquez
Thomas Michael Hiller
Ferdia Bates
Germany
Germany
Germany
Germany
Germany
SHOMER, ISAAC
2020-12-2217131713HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2BioNTech SEPatented Case2023-09-1911760809US20210189000A1
Wolfgang Scholz
Ritsuko Sawada
United States
United States
YAO, LEI
2020-12-0716972794Compositions and Methods for Diagnosis and Treatment of CancerBioNTech SEPatented Case2023-06-1311673939US20210246191A1
Ugur Sahin
Bonny Gaby Lui
Nadja Salomon
Joycelyn Wüstehube-Lausch
Matin Daneschdar
Hans-Ulrich Schmoldt
Markus Fiedler
Germany
Germany
Germany
Germany
Germany
Germany
Germany
MIKNIS, ZACHARY J
2020-09-0417012599METHOD FOR REDUCING IMMUNOGENICITY OF RNABioNTech SEPatented Case2024-01-1611873478US20200399629A1
Katalin Kariko
Ugur Sahin
United States
Germany
BERTOGLIO, VALARIE E
2020-07-0216920286INDIVIDUALIZED VACCINES FOR CANCERBioNTech SE
TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gG
Patented Case2022-02-1511248264US20210164034A1
Ugur Sahin
Sebastian Kreiter
Mustafa Diken
Jan Diekmann
Michael Koslowski
Cedrik Britten
John Christopher Castle
Martin Löwer
Bernhard Renard
Tana Omokoko
Johannes Hendrikus De Graaf
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
MONTANARI, DAVID A
2020-04-2216855703MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137BIONTECH SE
GENMAB A/S
Patented Case2021-08-1011084882US20200247899A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Friederike GIESEKE
Ugur SAHIN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
GAMBEL, PHILLIP
2020-04-1716757054PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPYBioNTech SEPatented Case2022-07-2611395799US20200246267A1
Heinrich Haas
Sebastian Hörner
Isaac Hernan Esparza Borquez
Thomas Michael Hiller
Ferdia Bates
Germany
Germany
Germany
Germany
Germany
SHOMER, ISAAC
2020-03-3116607054SYSTEM FOR SUPPORTING TEAMWORK BY MEANS OF AUGMENTED REALITYBioNTech SEPatented Case2025-07-0112346849US20230196223A1
Robert Hoffmeister
Germany
NGUYEN, NGA B
2020-03-0316644079SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7BIONTECH SEPatented Case2022-03-2211279684US20210002249A1
Christophe HENRY
Germany
OTTON, ALICIA L
2020-03-0316644076SUBSTITUTED IMIDAZOQUINOLINESBIONTECH SEPatented Case2022-03-0811267813US20200317663A1
Christophe HENRY
Germany
CHANDRAKUMAR, NIZAL S
2020-01-3116779011BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOFBIONTECH SE
GENMAB A/S
Patented Case2021-04-0610968280US20200165349A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Ugur SAHIN
Friederike GIESEKE
Alexander MUIK
Christian GRUNWITZ
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
Germany
Germany
DUFFY, BRADLEY
2019-12-0616620459METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPYBioNTech SEPatented Case2025-04-0812270813US20200209251A1
Ugur Sahin
Germany
HILL, MYRON G
2019-01-0916316534METHODS OF PRODUCING MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137BioNTech SE
GENMAB A/S
Patented Case2021-08-1711091557US20200062853A1
Isil ALTINTAS
David SATIJN
Rik RADEMAKER
Paul PARREN
Friederike GIESEKE
Ugur SAHIN
Netherlands
Netherlands
Netherlands
Netherlands
Germany
Germany
GAMBEL, PHILLIP
2016-11-0815309686PARTICLES COMPRISING PROTAMINE AND RNA IN COMBINATION WITH ENDOSOME DESTABILIZING AGENTSBioNTech SEPatented Case2020-08-0410729785US20170151349A1
Steve Pascolo
Switzerland
WHITEMAN, BRIAN A